Did Xiamen Shan Zhi Bio-ipo fail?

No The 6th1review meeting of the GEM Listing Committee in 2022 was held on September 6th, 2022. Xiamen Shan Zhi Biotechnology Co., Ltd. successfully applied for the IPO of GEM, but failed. Citic Securities is its sponsor and plans to raise 9.310.44 billion yuan. Shan Zhi Bio, founded on 20 10, is a life science enterprise with molecular diagnostic technology as the core and integrating the research, development, production and sales of molecular diagnostic reagents and instruments.